Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Technion Researchers Discover Group of Genes that Prevent Parkinson’s
Error: Contact form not found.
by Deby Medrez Pier
Technion University Medical School. Photo: wiki commons.
Members of the Rappaport Faculty of Medicine at Technion University in Israel have identified five genes that can predict Parkinson’s disease.
The scientists set out to evaluate whether a gene signature could be identified in the blood of early Parkinson’s disease patients and tests were run on blood samples from 62 early stage Parkinson’s disease patients.
“Currently, there is no blood test that can diagnose PD, making the detection of individuals at risk or at earliest stages of PD practically impossible. Instead it is identified by a clinical neurological examination based on findings suggestive of Parkinson’s disease,” said Dr. Silvia Mandel, Vice Director of the Eve Topf Center of Excellence for Neurodegenerative Diseases Research and Teaching.
Dr. Mandel added that “finding biomarkers for Parkinson’s disease will help to capture those high-risk subjects before symptoms develop, a stage where prevention treatment efforts might be expected to have their greatest impact to slow disease progression.”
The Rappaport Faculty of Medicine is home to Professors Avram Hershko and Aaron Ciechanover, both of whom won the 2004 Nobel Prize in Chemistry.
